Ataraxis AI

Ataraxis

The company develops artificial intelligence diagnostic tools for breast cancer to help clinicians predict treatment response and recurrence risk from patient data.

Artera

This company develops artificial intelligence tests that predict cancer outcomes and treatment benefits for clinicians and their patients.

StratifAI

This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.

AI Pathology

This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.

Omica

This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.

Azra

This company develops an artificial intelligence platform to automate oncology workflows and patient navigation for health systems and cancer centres.

Healthier Intelligence

This company develops an artificial intelligence clinical reasoning engine for oncologists and patients to summarise medical records and support treatment decisions.

Spotlight Medical

This company develops AI-driven prognosis tests to help oncologists select the most effective treatments for cancer patients.